The groundbreaking treatment of the medication represents a significant advance in the management of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatidepeptide066751.wssblogs.com/41903514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment